Position in SCLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,068
+$10,789 QoQ
Shares Held
1,419
+2017.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 72 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $64,664,035 across 17 Drug Manufacturers - General names. SCLX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,831 | $26,184,758 | |
| 2 | ABBV |
AbbVie Inc.
|
35,918 | $9,038,405 | |
| 3 | MRK |
Merck & Co., Inc.
|
63,932 | $8,215,262 | |
| 4 | PFE |
Pfizer Inc
|
310,250 | $7,470,820 | |
| 5 | JNJ |
Johnson & Johnson
|
27,845 | $7,071,794 | |
| 6 | AMGN |
Amgen Inc
|
7,025 | $2,543,893 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,994 | $1,497,774 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
11,716 | $1,480,199 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,068 | 1,419 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $279 | 42 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $512 | 42 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $826 | 42 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $247 | 42 | Shares | Sole | 2025-08-08 | |
| 2023-06-30 | $12,421 | 2,230 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $18,286 | 2,230 | Shares | Sole | 2023-05-04 | |
| No filing history on record for this holder in this stock. | ||||||